麻豆区 Tech researcher Nick Housley is developing a drug鈥慸elivery system designed to send cancer treatments directly to tumors while minimizing damage to healthy tissue. His team鈥檚 approach uses self鈥慳ssembling nanohydrogels (SANGs) that circulate through the body, remain inactive in healthy environments, and release their drug payload only when they encounter the unique chemical conditions created by tumors. This 鈥渃ancer鈥慳gnostic鈥 strategy avoids the pitfalls of traditional targeted therapies, which can lose effectiveness as tumors evolve, and aims to reduce the harsh side effects patients often endure. Early preclinical results show that the nanohydrogels successfully concentrated drugs at tumor sites, and Housley鈥檚 team is now preparing for broader testing to move the technology toward clinical trials.
